IQE completes £81m fundraise at a 25% dilution
IQE (AIM:IQE) completed an £81m fundraising through the issue of 332.18m new shares, lifting its total issued share capital to 1.31bn shares and diluting existing holders by 25.3%. The raise is the company's most significant capital event in recent years and provides a substantial funding base for the compound semiconductor wafer specialist. Shares fell 7.99% to 46.65p on the day, a typical market reaction to the dilution mechanics of a raise of this scale.
IQE guides for more than 20% revenue growth in FY2026
Alongside the fundraise, IQE issued a trading update in which management guided for revenue growth of more than 20% year-on-year in FY2026, with adjusted EBITDA expected to reach a high-single digit to low-double digit percentage range. The guidance frames the capital raise as a growth-enabling move rather than a distress event, with the company signalling confidence in the trajectory of its core business as demand for compound semiconductors continues to build.
MicroSalt lifts FY26 sales guidance after strong revenue jump
MicroSalt (AIM:SALT) upgraded its FY2026 sales guidance to US$4.5m after reporting FY2025 revenue of US$2.1m, a meaningful step-up for the low-sodium salt maker, while narrowing its net loss to US$3.2m. The results confirm the company is scaling commercial traction in its target markets, with the guidance upgrade signalling management's confidence in the growth trajectory continuing into the current year. Shares slipped 6.25% to 45.0p, likely reflecting profit-taking or broader dilution concerns in the small-cap space rather than any negative read on the underlying numbers.
GreenX Metals outlines large copper-silver target at Tannenberg
GreenX Metals (AIM:GRX) published an Exploration Target of 144-279 Mt at its Tannenberg project in Germany, representing 1.3-3.9 Mt of contained copper and 69-188 Moz of contained silver. The scale of the target places Tannenberg among the more significant European critical minerals prospects in the small-cap space, and the company confirmed it will now transition from archive and desktop work to active field programmes. Shares rose 5.95% to 51.385p on the announcement.
BSF Enterprise lists lab-grown T-rex leather handbag at €500,000
BSF Enterprise (AIM:BSFA) announced that its Lab-Grown Leather subsidiary's flagship bio-engineered T-rex leather handbag will be featured in the catalogue of Paris auction house Hôtel Drouot, carrying an official price estimate of €500,000. The listing represents a high-profile commercial and marketing milestone for the company's novel materials business, positioning the product at the intersection of luxury goods and biotechnology. Shares edged up 2.14% to 1.7875p.
DP Poland forecasts double-digit system sales growth for 2025
DP Poland (AIM:DPP) reported full-year revenue of £61.7m for the year ended 31 December 2025, up 15% year-on-year, and said it expects double-digit system sales growth in the current year. The Domino's Pizza franchise operator for Poland and Croatia has built consistent momentum across both markets, and the forward guidance from chief executive Nils Gornall points to continued expansion of the store network and underlying sales volumes. Shares gained 2.67% to 7.7p.
Great Western signs six-year earn-in option with KGHM at Eastside-Tango
Great Western Mining Corporation (AIM:GWMO) signed an option agreement with Polish mining giant KGHM, granting the major the right to earn up to 100% of the Eastside-Tango copper project in Nevada over a six-year period. The deal includes staged cash payments, a commitment to spend at least US$5m on exploration, and royalty upside retained by Great Western. The structure hands a well-capitalised partner the operational burden while preserving meaningful economic exposure for the London-listed junior. Shares fell 3.33% to 3.915p.
Petro Matad awaits PetroChina sign-off on 2026 Oil Sales Agreement
Petro Matad (AIM:MATD) confirmed it has approximately 35,000 barrels of Block XX crude in storage as production holds steady, and that management is urgently evaluating a late-June 3D seismic shoot to advance the project's subsurface understanding. The company is awaiting formal sign-off from PetroChina on the 2026 Oil Sales Agreement, a key commercial step required to monetise the stored inventory. Shares were broadly flat, adding 0.18% to 1.2422p.
Touchstone Exploration brings two WD-8 wells into production
Touchstone Exploration (AIM:TXP) brought two WD-8 wells online, adding near-term production capacity as the Trinidad-focused oil and gas company continues to convert its reserves base into cash flow. Chief executive Paul Baay described operational focus as centred on "efficiently converting reserves into near-term cash flow", a message consistent with the company's capital-disciplined approach in the current environment. Shares dipped marginally by 0.69% to 7.2p.
Ultimate Products reports quarterly sales marginally ahead of expectations
Ultimate Products (AIM:ULTP) said overall revenues were stable in its latest quarter and came in slightly ahead of management expectations, a modest but reassuring beat for the branded household goods supplier. Chief executive Andrew Gossage described the result as pleasing given the broader consumer backdrop, and the company's shares responded positively, rising 1.96% to 52.0p.
Oriole Resources flags high-grade rock chips at Eastern CLP
Oriole Resources (AIM:ORR) reported high-grade rock chip results from its Eastern CLP exploration work, with management stating the findings continue to support the "significant prospectivity and potential" for further gold discoveries at the project. The results add to a growing body of evidence at the licence area and are expected to inform the next phase of field activity. Shares jumped 6.9% to 0.31p on the news.
SkinBioTherapeutics board completes internal investigation
SkinBioTherapeutics (AIM:SBTX) confirmed its board has completed its internal investigation, a process that has weighed on the company in recent months. The company also confirmed the appointment of Saffrey as its new auditor and said further details on next steps would be announced shortly. Shares fell 4.88% to 9.75p, with the market appearing to await more substantive disclosure before reassessing the stock.
Nuformix advances NXP002 partnering discussions with FDA orphan designation
Nuformix (AIM:NFX) published results highlighting progress across its pipeline, with management pointing to its inhaled IPF treatment NXP002 as a "viable and attractive concept" supported by ongoing external discussions. The company's FDA orphan designation for NXP002 is actively assisting partnering conversations, providing a regulatory hook that adds credibility to the programme in discussions with potential development partners. Shares were quoted at 0.17p.
Physiomics develops hantavirus translational modelling framework
Physiomics (AIM:PYC) disclosed the development of a hantavirus translational modelling workflow that links in vitro antiviral screening data to human pharmacokinetic and pharmacodynamic modelling and virtual population simulations. The framework is designed to assess whether laboratory-level antiviral activity could translate into meaningful clinical viral suppression, a capability that positions the company as a specialist modelling partner for infectious disease programmes. Shares edged down 1.81% to 0.6873p.
